The neurotoxic lesion produced by direct injection of 25 nmol of N-methyl-o-aspartate (NMDA) into the corpus striatum of 7-dayold rats was compared to the effects of injecting 75 nmol into the striatum or hippocampus of adults. The area of histopathology in the immature striatum was 21 x larger than the striatal lesion in adults. Damage from NMDA injected into the immature striatum also extended into the dorsal hippocampus and produced an area of destruction which was 16 x larger than observed after direct injection into the adult hippocampus. Several studies have implicated excessive N-methyl-D-aspartate receptor activation in the pathogenesis of hypoxic-ischemic and hypoglycemic injury and our results suggest that this neurotoxic mechanism is extremely active in the immature brain.
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Glutamate is one of the principle excitatory amino acid (EAA) neurotransmitters in the mammalian brain 7'31. Glutamate mediates different cellular responses by interacting with several receptor subtypes named by their preferential agonists: N-methyl-D-aspartate (NMDA), quisqualic acid (QA) and kainic acid (KA) 15'31. The excitatory responses of glutamate are terminated by a presynaptic high capacity uptake system that clears glutamate from the synaptic cleft t. Imbalance between the mechanisms responsible for synaptic release and uptake of glutamate could cause glutamate accumulation in the synaptic cleft and excessive excitation of EAA receptors. Overexcitation of EAA receptors can initiate a cascade of events 2°'24 leading to excessive calcium entry, neuronal injury and death 9'17A8. Synthetic and alkaloid agonists of each of the EAA receptors have been found to be neurotoxic in both the developing 4'25'28 and mature 6'8'29 rat central nervous system (CNS). Furthermore there are compounds endogenous to the brain that are not themselves neurotransmitters but which have neurotoxic actions mediated at EAA receptors. For example, quinolinic acid (QUIN), an endogenous metabolite of tryptophan, is an NMDA receptor neuromodulator and a potent neurotoxin in the adult CNS 23.
Neuronal susceptibility to the toxicity produced by EAA receptor agonists changes during development. For example, QA appears to be more toxic in the developing CNS 25 than in the CNS of adults t1'32 whereas the capacity of KA to induce neuronal injury increases with age and parallels the development of glutamatergic pathways 2. The non-selective glutamate agonist ibotenate appears equally toxic in the developing and mature CNS. In the present study, we report that the neurotoxicity of NMDA is greatly enhanced in the immature rat brain.
Intracerebral injections of NMDA were performed in 7-day-old (n = 10) and in adult (3-monthold, n = 10) Sprague-Dawley albino rats briefly anesthetized with ether 13. Stereotaxic injections in adults were made through a burr hole in the calvarium by means of a Hamilton syringe (26 gauge) into the corpus striatum (n = 5; bregma, AP 0, ML 3.0, V 5.5 mm) or the dorsal hippocampus (n = 5; bregma, AP 3.5, ML 3.5, V 3 mm). Seven-day-old rat pups
